Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.
Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K, Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T. Nakatsuka E, et al. Among authors: kodama m. Oncotarget. 2017 Sep 12;8(52):89887-89902. doi: 10.18632/oncotarget.20834. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163796 Free PMC article.
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T. Yoshimura A, et al. Among authors: kodama m. BMC Cancer. 2018 Nov 5;18(1):1065. doi: 10.1186/s12885-018-4974-5. BMC Cancer. 2018. PMID: 30396333 Free PMC article.
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer.
Kuroda H, Mabuchi S, Yokoi E, Komura N, Kozasa K, Matsumoto Y, Kawano M, Takahashi R, Sasano T, Shimura K, Kodama M, Hashimoto K, Sawada K, Morii E, Kimura T. Kuroda H, et al. Among authors: kodama m. Oncotarget. 2018 Nov 20;9(91):36317-36330. doi: 10.18632/oncotarget.26347. eCollection 2018 Nov 20. Oncotarget. 2018. PMID: 30555631 Free PMC article.
Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models.
Kozasa K, Mabuchi S, Matsumoto Y, Kuroda H, Yokoi E, Komura N, Kawano M, Takahashi R, Sasano T, Shimura K, Kodama M, Hashimoto K, Sawada K, Nagasaka K, Kimura T. Kozasa K, et al. Among authors: kodama m. Oncotarget. 2019 Mar 8;10(20):1887-1902. doi: 10.18632/oncotarget.26711. eCollection 2019 Mar 8. Oncotarget. 2019. PMID: 30956772 Free PMC article.
The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations.
Yokoi E, Mabuchi S, Komura N, Shimura K, Kuroda H, Kozasa K, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T. Yokoi E, et al. Among authors: kodama m. Oncoimmunology. 2019 Sep 25;8(12):e1662708. doi: 10.1080/2162402X.2019.1662708. eCollection 2019. Oncoimmunology. 2019. PMID: 31741758 Free PMC article.
Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer.
Kobayashi M, Sawada K, Miyamoto M, Shimizu A, Yamamoto M, Kinose Y, Nakamura K, Kawano M, Kodama M, Hashimoto K, Kimura T. Kobayashi M, et al. Among authors: kodama m. Biochem Biophys Res Commun. 2020 Jun 18;527(1):153-161. doi: 10.1016/j.bbrc.2020.04.076. Epub 2020 Apr 28. Biochem Biophys Res Commun. 2020. PMID: 32446360
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Komura N, Mabuchi S, Shimura K, Yokoi E, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T. Komura N, et al. Among authors: kodama m. Cancer Immunol Immunother. 2020 Dec;69(12):2477-2499. doi: 10.1007/s00262-020-02628-2. Epub 2020 Jun 19. Cancer Immunol Immunother. 2020. PMID: 32561967 Free PMC article.
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, Kodama M, Hashimoto K, Kimura T. Shimizu A, et al. Among authors: kodama m. Mol Cancer Res. 2021 Sep;19(9):1583-1595. doi: 10.1158/1541-7786.MCR-20-0956. Epub 2021 May 20. Mol Cancer Res. 2021. PMID: 34016744
1,577 results